Form 4: AnaptysBio Director Executes Option Repricing
Statement of Changes in Beneficial Ownership
Director John P. Schmid adjusted his stock option holdings following the spin-off of First Tracks.
Summary
- Director John P. Schmid completed a series of stock option exchanges on April 20, 2026.
- The transactions involved the cancellation of existing options and the issuance of new options with adjusted strike prices.
- This adjustment was executed on a pro-rata basis following the separation and distribution agreement between AnaptysBio and First Tracks.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing related to a corporate restructuring event rather than a signal of operational performance.
Positives
- The adjustments maintain the economic value of the director's equity compensation following the corporate spin-off.
Negatives
- The repricing reflects a significant decline in the underlying strike prices of the options, which is a direct consequence of the corporate separation and asset distribution.
Risks
- The company is undergoing a structural separation, which introduces operational and market risks associated with the new entity, First Tracks.
Future Outlook
The filing does not provide forward-looking guidance on company performance, focusing strictly on the mechanical adjustment of equity instruments due to the corporate separation.
Management Comments
- The adjustments were made pursuant to the Separation and Distribution Agreement dated April 20, 2026.
Industry Context
StockSavvy.ai notes that corporate spin-offs frequently necessitate the mechanical repricing of executive and director equity awards to ensure that the intrinsic value of the options remains consistent with the pre-spin valuation.
Comparison to Industry Standards
- The adjustment methodology follows standard corporate governance practices for spin-offs, ensuring that option holders are not unfairly penalized or rewarded by the corporate restructuring.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Adjustment | Pro-rata adjustment of outstanding stock options due to the separation of First Tracks. | 04/20/2026 | Neutral; maintains the status quo of director equity incentives. |
Stakeholder Impact
- Shareholders should note the dilution or structural changes resulting from the separation of First Tracks.
Next Steps
- Continued service of the director to satisfy remaining vesting requirements for the 2036 option series.
Key Dates
| Date | Description |
|---|---|
| 02/06/2026 | Commencement of vesting for the most recent option grant. |
| 04/20/2026 | Date of the separation agreement and the effective date of the option adjustments. |
| 04/22/2026 | Date of filing. |
Keywords
AnaptysBio, ANAB, Form 4, Stock Options, Spin-off, Director Compensation, First Tracks
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.